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Autophagy requires the formation of membrane vesicles, known as autophagosomes, that engulf 
cellular cargoes and subsequently recruit lysosomal hydrolases for the degradation of their contents. A 
number of proteins are required for autophagy that act to mediate the de novo biogenesis of 
autophagosomes and vesicular trafficking events. Of these proteins, ATG16L1 is a key player that has 
important functions at various stages of autophagy. Numerous recent studies have begun to unravel 
novel activities of ATG16L1, including interactions with proteins and lipids, and how these mediate its 
role during autophagy and autophagy-related processes. Various domains have been identified within 
ATG16L1 that mediate its functions in recognising single and double membranes and activating 
subsequent autophagy-related enzymatic activities required for the recruitment of lysosomes. These 
recent findings, as well as the historical discovery of ATG16L1, pathological relevance, unresolved 




Autophagosomes are distinct double membrane vesicles that form de novo to encapsulate and deliver 
cellular components for lysosomal degradation in a process known as macroautophagy (hereafter 
referred to as autophagy). The activities of autophagy-related (ATG) proteins are essential for the 
recognition of degradation substrates and for autophagosome biogenesis (Gatica et al., 2018; Lamb et 
al., 2013). A subset of ATG proteins is also involved in so-called non-canonical autophagy or autophagy-
related processes, which engage pre-formed single membrane vesicles (Galluzzi and Green, 2019). 
Regulation of ATG protein activities is essential to ensure the proper recruitment of lysosomes and to 
prevent aberrant degradation of cellular contents.  
At the heart of autophagy, two ubiquitin-like conjugation machineries exist (Mizushima, 2019). These 
act to mediate the conjugation of ubiquitin-like proteins, including ATG12 and members of the ATG8 
family of proteins, to ATG5 and the phospholipid phosphatidylethanolamine (PE), respectively. The two 
conjugation reactions require the common E1-like ubiquitin ligase ATG7, but distinct E2-like enzymes, 
ATG10 and ATG3, for the conjugation of ATG12 and ATG8 proteins, respectively. While no E3-like 
enzyme has been described for ATG12 conjugation, it is now established that the ATG5-ATG12 
conjugate, in complex with ATG16L1 (Mizushima et al., 2003), harbours an E3-like activity during ATG8-
PE conjugation (Fracchiolla et al., 2020; Lystad et al., 2019). Given that the ATG5-ATG12 conjugate is 
constitutively formed in cells, it can be predicted that the regulation of ATG8 conjugation, which is 
indicative of autophagic activity, occurs through the regulation of membrane availability, lipid 
modification, enzymatic activities and protein localisation (Martens and Fracchiolla, 2020).  
ATG16L1 plays a crucial role during various steps leading to the conjugation of ATG8 proteins and 
accumulating recent data have revealed multifaceted activities of this autophagy essential factor (Fig. 
1). This review will discuss in depth the function and regulation of ATG16L1 during autophagy and 
autophagy-related processes. The specific domains of ATG16L1 that mediate its functions as well as its 
pathophysiological relevance will also be examined. 
 
Brief outline of autophagosome formation 
The characteristic double membrane nature of autophagosomes led to their initial identification as 
distinct organelles (Hollenstein and Kraft, 2020; Kawabata and Yoshimori, 2020; Yang and Klionsky, 
2010) (Fig. 2A). Autophagy occurs at basal levels in cells and can be further induced upon various 
stimuli such as nutrient and oxygen deprivation as well as genotoxic and cytotoxic stresses (Antonucci 
et al., 2015; Kroemer et al., 2010; Mizushima et al., 2004; Russell et al., 2014). A number of protein 
complexes act to relay autophagy-stimulatory signals and engage in membrane modifications in order 
to facilitate the recruitment of the core ATG machinery to the pre-autophagosomal membrane 
(known as the phagophore or isolation membrane) (Box 1).  Of these, the ULK complex, comprised of 
the ULK1 or ULK2 kinases and their adaptor proteins FIP200, ATG13 and ATG101, can be activated 
following autophagy-inducing stimuli (Wong et al., 2013) leading to the subsequent stimulation of 
VPS34 complex which catalyses the generation of phosphatidylinositol-3-phosphate (PI(3)P) on the 
phagophore (Russell et al., 2014). PI(3)P is required for the phagophore recruitment of the WIPI family 
of proteins (including WIPI1 and WIPI2) and the ATG5 complex (comprised of the ATG5-ATG12 
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conjugate bound to ATG16L1) (Itakura and Mizushima, 2010). The ATG5 complex can stimulate the 
lipid conjugation of ATG8 proteins, which include the LC3 (LC3A, LC3B and LC3C) and GABARAP 
(GABARAP, GABARAPL1 and GABARAPL2) sub-families (Johansen and Lamark, 2020; Mizushima, 
2019). The eventual fusion of lysosomes with autophagosomes (forming autolysosomes) requires 
components of the endocytic pathway and is key for the execution of a complete autophagic 
degradation (known as flux) (du Toit et al., 2018; Loos et al., 2014).  
 
Brief outline of ATG8 conjugation on single membranes  
Single membrane ATG8 conjugation (SMAC) (Durgan et al., 2020) has been reported and is a topic of 
emerging interest (Heckmann and Green, 2019; Sanjuan et al., 2007). SMAC involves the lipid 
conjugation of ATG8 proteins on already formed membranes and does not require membrane 
nucleation and growth, as is the case for autophagosome biogenesis (Fig. 2B). This non-canonical form 
of ATG8 lipidation can occur in the absence of the ULK and VPS34 complexes, but invariably requires 
the core ATG lipidation machinery, including ATG7 and the ATG5 complex (Florey et al., 2015; Florey 
et al., 2011; Martinez et al., 2011). Our current understanding of the underlying molecular 
mechanisms that mediate SMAC and the relevance of ATG16L1 will be discussed throughout this 
review. 
 
Identification and structural organisation of ATG16L1/Atg16  
Identification 
The identification of most ATG gene products (Atg1-Atg15) was performed in yeast using a screen for 
mutants that were unable to grow under nitrogen starvation conditions (Tsukada and Ohsumi, 1993). 
Atg16 (initially termed Apg16) was identified several years later using a yeast two-hybrid screen for 
yeast Atg12-interacting partners (Mizushima et al., 1999) and was followed by the identification of 
mammalian ATG16L1 (initially termed Apg16-like, Apg16L) by co-immunoprecipitation with ATG5 from 
mouse cells (Mizushima et al., 2003). Mammalian ATG16L1 and yeast Atg16 share high homology except 
for the presence of additional sequences within the C-terminal of ATG16L1 that are absent in its yeast 
counterpart (Fujioka et al., 2010) (Fig. 3). Three main splice isoforms of mouse ATG16L1 were identified 
(α, β and E) that differ in sequences within their middle region as well as exhibit variable tissue 
expression patterns (Ishibashi et al., 2011; Mizushima et al., 2003).  
 
Domains and structural organisation  
ATG16L1 can be divided into three main domains that contribute to its distinct functions: an N-terminal 
region containing an ATG5 binding domain, a middle region containing a coiled-coil domain (CCD) and 
seven WD40 domains located within its C-terminal half (Fig. 1). The tertiary structures of these three 
domains have been individually determined providing a prediction of the overall structural organisation 
of the full length protein (Wilson et al., 2014). Mutations in individual domains of ATG16L1 enable the 
distinction of various forms of autophagy and autophagy-related processes (Fletcher et al., 2018; 
Gammoh et al., 2013).  
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ATG16L1/Atg16 proteins likely exist in dimeric forms (Fujioka et al., 2010; Fujita et al., 2009). 
Dimerisation of ATG16L1 occurs mainly through CCD sequences (Fujioka et al., 2010; Parkhouse et al., 
2013) although dimerisation activities have also been detected in the N-terminal and WD40 domains of 
ATG16L1 (Bajagic et al., 2017; Kim et al., 2015). Size exclusion chromatography indicates that ATG16L1 
exists in an approximately 800 kDa complex in cells, which is about three times the predicted size of an 
individual ATG16L1 dimer bound to two ATG5-ATG12 molecules (~250 kDa in size) (Ishibashi et al., 2011; 
Lystad et al., 2019; Mizushima et al., 2003). The two factors that are required for formation of this large 
molecular complex are binding to ATG5 and dimerisation via the CCD (Mizushima et al., 2003; Saitoh et 
al., 2008). The precise components of this higher molecular weight complex are not fully understood. It 
is possible that solution-exposed amino acid residues within the CCD can mediate multimerisation of 
ATG16L1 as suggested by computational modelling (Kaufmann et al., 2014). This however remains to be 
experimentally confirmed as the use of sucrose density gradients as alternative methods to predict 
complex sizes suggest that ATG16L1 is mainly found as a dimer in cells (Fujita et al., 2009). 
 
N-terminus 
The N-terminus of ATG16L1 (residues 1-70) consists of an α-helix followed by a tail region and contains 
sequences required for binding to the ubiquitin-folds of ATG5 (Matsushita et al., 2007; Otomo et al., 
2013). This interaction requires residues R35 and F46 of yeast Atg16 (corresponding to R24 and I36 of 
mammalian ATG16L1) and is essential for autophagy (Matsushita et al., 2007). The existence of 
additional residues in mammalian ATG16L1 (I17 and L21) required for ATG5 binding may suggest a 
divergence in the interaction between ATG16L1/Atg16 and ATG5/Atg5 between mammalian and yeast 
proteins (Kim et al., 2015; Mizushima et al., 2003). The N-terminus of ATG16L1 also harbours a 
membrane binding activity required for ATG8 lipidation (Lystad et al., 2019) (Fig. 1). The lipidation 
stimulatory activity of the ATG16L1 N-terminus is further supported by its ectopic plasma-membrane 
tethering, which was shown to be sufficient to drive LC3 lipidation in cells (Fujita et al., 2008). The E3-
like ubiquitin ligase activity of the ATG5 complex is discussed further below. 
 
CCD and the middle region 
 Coiled-coil regions are composed of helical structures that are known to contribute to protein-protein 
interactions. In ATG16L1, hydrophobic sequences within the CCD mediate its homodimerization (Fujioka 
et al., 2010), while solution-exposed residues can mediate binding to lipid and protein interactors, 
including phospholipids (Dudley et al., 2019) and Rab33B (Itoh et al., 2008). Interacting partners of yeast 
Atg16 CCD were also identified, including the PI(3)P effector Atg21 (Juris et al., 2015). Further 
downstream of the CCD within the middle region of ATG16L1, sequences that mediate interactions with 
WIPI2b (an isoform of WIPI2) (Dooley et al., 2014), FIP200 (Gammoh et al., 2013; Nishimura et al., 2013) 
and lipids (Lystad et al., 2019) have been described. These sequences are absent from yeast Atg16 and 
their lengths differ between the ATG16L1 isoforms (highlighted in Fig. 3). 
The CCD is essential for autophagy and its deletion causes neonatal lethality in mice, which mimics 
knockout of core ATG genes (Saitoh et al., 2008). The importance of the middle region of ATG16L1 has 
been further highlighted by several observations. First, overexpression of ATG16L1 in some cell lines 
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leads to the inhibition of LC3 lipidation in a manner dependent on its middle region (amino acids 80-265 
of mouse ATG16L1) (Fujita et al., 2008; Li et al., 2017a). Second, mutations in conserved and solvent-
exposed residues of yeast Atg16 CCD, which do not contribute to the dimer-dimer interface, resulted in 
autophagy inhibition, suggesting a relevance of the CCD beyond dimer formation (Fujioka et al., 2010). 
Finally, the structurally-related and closely homologous ATG16L2 lacks LC3-lipidation-stimulating activity 
during canonical autophagy and can potentially exhibit inhibitory effects (Ishibashi et al., 2011; Khor et 
al., 2019; Wible et al., 2019). Elegant domain swapping experiments suggest that replacing the middle 
region of ATG16L2 with that of ATG16L1 can reconstitute LC3 lipidation to levels that are comparable to 
wild type ATG16L1 (Ishibashi et al., 2011). The absence of a localisation of ATG16L2 to phagophores is 
likely to explain its lack of autophagic activity as the ectopic localisation of its N-terminus to the plasma 
membrane can stimulate LC3 lipidation as seen with ATG16L1 (Fujita et al., 2008; Ishibashi et al., 2011). 
ATG16L2 can bind ATG5 and homodimerise, but it does not bind WIPI2b nor FIP200 and has reduced 
affinity to Rab33B, further highlighting the importance of the middle region of ATG16L1 (Dooley et al., 
2014; Gammoh et al., 2013; Ishibashi et al., 2011). As residues that mediate these interactions are 
absent in yeast Atg16, it remains to be determined whether binding to these factors is sufficient to 
explain the lack of ATG16L2 autophagic activity.  
 
WD40 domains 
 Seven WD40 domains span the C-terminal half of ATG16L1 and are absent in Atg16, indicating that they 
are dispensable for the role of ATG16L1 in canonical autophagy (Fletcher et al., 2018; Gammoh et al., 
2013) (Fig. 1). Recent studies have begun to unfold a non-canonical SMAC function of this region 
(Fletcher et al., 2018). The WD40 domains of ATG16L1 form a seven-bladed propeller (Bajagic et al., 
2017) and are involved in multiple protein-protein interactions, as discussed further below. Mice 
harbouring deletion in the WD40 domains of ATG16L1 exhibited no phenotypic abnormalities or 
neonatal fatality in contrast to the loss of ATG16L1 CCD (Rai et al., 2019; Saitoh et al., 2008). Bone 
marrow-derived dendritic cells from mice lacking the WD40 domains of ATG16L1 showed defective 
MHC class II antigen presentation attributed to the non-canonical activity of ATG16L1 in facilitating LC3 
lipidation on single membranes (Fletcher et al., 2018). In addition, these animals exhibited an increased 
sensitivity to influenza A infection and reduced survival when compared to their control counterparts 
(Wang et al., 2020). The exact mechanisms through which the WD40 domains mediate SMAC remain to 
be determined and likely involve yet unidentified interactions that include conserved residues within the 
top face of the WD40 domains (Fletcher et al., 2018).  
 
Function of ATG16L1 at different stages of autophagy 
Phagophore recruitment of the ATG5-ATG12 conjugate 
Accumulating recent studies show that the phagophore recruitment of the ATG5 complex is mediated 
through ATG16L1 (Dudley et al., 2019; Juris et al., 2015; Li et al., 2017a) and is therefore a critical 
regulatory step during autophagosome biogenesis. The phagophore localisation of ATG16L1 requires 
components of the ULK complex, as well as VPS34-mediated PI(3)P production (Fig. 2A) (Itakura and 
Mizushima, 2010). Live-imaging studies suggest that ATG16L1 (bound to ATG5) and the ULK complex 
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concurrently localise to the growing phagophore (Koyama-Honda et al., 2013). This is likely mediated by 
the direct binding of ATG16L1 to the ULK complex component FIP200 (Gammoh et al., 2013; Nishimura 
et al., 2013). Genetic inhibition of FIP200 or deletion of the FIP200-binding domain of ATG16L1 
abrogates puncta formation of the ATG5 complex (Gammoh et al., 2013; Nishimura et al., 2013). The 
phagophore localisation of ATG16L1, but not the ULK complex, requires PI(3)P (Itakura and Mizushima, 
2010), indicating that it may occur in a two-step manner, whereby initial recruitment of ATG16L1 is 
followed by its stabilisation on membranes.  
The requirement of PI(3)P for the phagophore recruitment of ATG16L1 can be mediated by direct 
interaction of ATG16L1 to phosphoinositides, as well as binding to the PI(3)P effector WIPI2b (Dooley et 
al., 2014; Dudley et al., 2019). The requirement of multiple interaction partners may be important to 
prevent the aberrant recruitment of ATG16L1 on other membranes (Dudley et al., 2019; Ravikumar et 
al., 2010). Yeast Atg21 (a phosphoinositide-binding protein) was shown to bind the CCD of Atg16 
(residues D101 and E102) (Juris et al., 2015). Genetic deletion of Atg21 in yeast does not fully disrupt 
starvation-induced Atg8 lipidation (Meiling-Wesse et al., 2004; Nair et al., 2010) but reduces autophagy 
and Atg16 phagophore recruitment under nutrient-rich conditions (Juris et al., 2015). Given that the 
Atg16
D101E102A
 mutant is deficient in autophagy (Fujioka et al., 2010), it is possible that these sites 
mediate additional autophagic functions of yeast Atg16. Interestingly, similar to the interaction 
between mammalian ATG5 and ULK complexes mediated by binding between ATG16L1 and FIP200 
(Gammoh et al., 2013; Nishimura et al., 2013), yeast Atg5 complex can also interact with the Atg1 
(ULK1 homologue) complex but requires binding between Atg12 and Atg17 (a functional homologue of 
FIP200) (Harada et al., 2019). This suggests that diverged but multi-factorial mechanisms exist to target 
the ATG5 and Atg5 complexes in mammalian and yeast systems, respectively.  
In mammals, PI(3)P, WIPI2b and FIP200 were shown to bind adjacent residues in the middle region of 
ATG16L1 (Fig. 1). How these interacting partners crosstalk to mediate the efficient phagophore 
recruitment of ATG16L1 remains to be determined. Given that these three factors are dispensable for 
the role of ATG16L1 in mediating LC3 lipidation during mTORC1-independent autophagy or on single 
membranes, it is likely that additional means exist to mediate ATG16L1 localisation to membranes 
(Fletcher et al., 2018; Gammoh et al., 2013; Lystad et al., 2019).  
In addition, the displacement of ATG16L1 from membranes also appears to be important for LC3 
lipidation with its regulation an open question. Enhancing the lipid-binding activity of ATG16L1 within its 
CCD, which is required for its phagophore recruitment, led to the inhibition of LC3 lipidation (Dudley et 
al., 2019). Similarly, unlike the plasma-membrane tethering of the N-terminal region of ATG16L1, 
tethering of a fragment that also includes the middle region (amino acids 1-249) to the plasma 
membrane inhibited LC3 lipidation (Park et al., 2016). These findings suggest that persistent membrane 
localisation of ATG16L1 can impose inhibitory effects on LC3 lipidation and its regulation is therefore 
crucial for autophagy.  
 
Membrane nucleation 
Beyond its role in recruiting the ATG5 complex to the phagophore, ATG16L1 can facilitate phagophore 
growth by localising to endocytic vesicles, which subsequently undergo fusion events (Fig. 2A) (Puri et 
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al., 2013; Ravikumar et al., 2010). Recycling endosomes that are positive for Rab11 and ATG16L1 are 
thought to originate from the plasma membrane, thereby potentially contributing to a membrane 
source for autophagosome biogenesis (Puri et al., 2013; Ravikumar et al., 2010). However, the 
localisation of ATG16L1 to endosomes is not sufficient to drive LC3 lipidation, as transiently expressed 
ATG16L1 that predominantly localises to Rab11-positive recycling endosomes results in autophagy 
inhibition (Li et al., 2017a). Indeed, the recruitment of factors such as WIPI2b to Rab11a-positive 
endosomes are thought to facilitate the role of ATG16L1 during LC3 lipidation (Puri et al., 2018).  
Similar to other membrane-fusion events, fusion of autophagy-related membranes appears to rely on 
the SNARE machinery. The homotypic fusion of ATG16L1-containing structures mainly requires VAMP7 
and its accessory proteins, whereas heterotypic fusion events between recycling endosomes containing 
ATG16L1 or the transmembrane ATG protein ATG9, is mediated by VAMP3 (Moreau et al., 2011; Puri et 
al., 2013). Knockdown of either VAMP3 or VAMP7 reduces the levels of lipidated LC3 (Moreau et al., 
2011; Puri et al., 2013). An involvement of Annexin A2 has also been documented (Morozova et al., 
2015). It is thought that Annexin A2 plays a part by influencing the phospholipid composition of 
ATG16L1-positive vesicles, as well as by supporting vesicle fusion events. Interestingly, Annexin A2 is 
also present at the plasma membrane and may thereby contribute to the plasma membrane 
recruitment of ATG16L1 (Morozova et al., 2015).   
 
Autophagosome maturation and ATG8 lipidation  
The ATG5 complex components are all essential for its E3-like ubiquitin ligase activity that is required for 
the lipidation of ATG8 proteins in vitro and in cells. This involves the recruitment of the E2-like ligase 
ATG3 to the site of autophagosome biogenesis through direct binding between ATG3 and ATG12 
(Otomo et al., 2013), as well as the ability of ATG16L1 to bind membranes through its N-terminal 
amphipathic helices (designated as helix 2) (Lystad et al., 2019). Helix 2 mutants of ATG16L1 form 
punctate structures similar to wild type protein, suggesting that its involvement in ATG8 lipidation 
occurs after its recruitment to phagophores. This N-terminal lipid-binding is required for both single and 
double membrane lipidation of ATG8s and may facilitate membrane remodelling events (Lystad et al., 
2019). A distinct membrane-binding activity of ATG16L1 located downstream from its CCD within the 
middle region termed β isoform lipid binding (Fig. 1) has been also described and is required for PI(3)P-
independent SMAC such as on perturbed endosomes (Lystad et al., 2019). SMAC was shown to involve 
ATG8 conjugation to phosphatidylserine (PS) as well as to PE (Durgan et al., 2020) thereby raising the 
possibility that the β isoform lipid binding exhibits a capacity to mediate ATG8 to additional 
phospholipids (Lystad et al., 2019). Interestingly, an isoform of ATG16L1 (ATG16L1α) lacks this second 
membrane-binding activity and, unlike its splice variant ATG16L1β, cannot support the lipidation of 
ATG8 during endosomal stress (Fig. 3) (Lystad et al., 2019). The tissue-specific expression relevance of 
these ATG16L1 isoforms remains largely unknown and elucidating these may help distinguish the roles 
of ATG16L1 during ATG8 lipidation on various membranes (Ishibashi et al., 2011). 
 
Interactions with Rab GTPases and relevance in autophagosome-lysosome fusion 
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Rab GTPases are a family of guanine nucleotide (GTP)-dependent exchange factors involved in various 
stages of vesicle formation and trafficking (Kiral et al., 2018; Zhen and Stenmark, 2015). They recruit 
specific downstream effectors when bound to GTP in their active state. Although their function is most 
extensively studied and linked to the endocytic pathway, accumulating data suggest they are also 
relevant during autophagosome biogenesis (Ao et al., 2014). Several Rab GTPases have been identified 
that can bind ATG16L1 and influence its subcellular localisation (Binotti et al., 2015; Itoh et al., 2008). 
The first indication that ATG16L1 can bind Rab GTPases came from a proteomic search for interacting 
partners of Rab33B, a Golgi-resident Rab GTPase with poorly defined function (Itoh et al., 2008). 
Subsequently, an interaction between ATG16L1 and Rab33A has also been described and shown to have 
autophagy-independent functions (discussed below) (Ishibashi et al., 2012; Itoh et al., 2008).  
The relevance of Rab33B-ATG16L1 interaction during autophagy remains poorly understood. RNAi-
mediated knockdown of Rab33B does not significantly affect LC3 lipidation but the expression of 
constitutively active Rab33B appears to elevate the levels of lipidated LC3 and the autophagy receptor 
p62 (Itoh et al., 2008). In addition, expression of OATL1 (also known as TBC1D25), a guanosine 
triphosphatase–activating protein (GAP) for Rab33B, also enhanced LC3 lipidation and ATG16L1 puncta 
formation (Itoh et al., 2011). More detailed analyses showed that OATL1 and Rab33B can act by 
facilitating autophagosome-lysosome fusion (Itoh et al., 2011). Whether the interaction of Rab33B with 
ATG16L1 is relevant for its effects during lysosome fusion remains to be determined and may indicate 
that ATG16L1 can influence downstream events during autophagy. An additional involvement of the 
ATG5 complex in autophagosome-lysosome fusion was revealed upon the identification of tectonin 
beta-propeller repeat containing 1 (TECPR1) as an ATG5 binding partner (Chen et al., 2012). Mutating 
ATG5 binding sites in TECPR1 leads to an increase in GFP-LC3 puncta, consistent with a perturbed fusion 
between autophagosomes and lysosomes (Kim et al., 2015). ATG16L1 is excluded from the ATG5-
TECPR1 complex and can be assumed to have an inhibitory effect on lysosome fusion in this setting 
(Chen et al., 2012).  
  
Regulation of ATG16L1 by post-translational modifications and stability   
Our current understanding highlights the importance of protein-protein and protein-lipid interactions in 
regulating the activities of most ATG proteins, including ATG16L1. Although many of these interactions 
appear constitutive and not affected by autophagy induction in cells (Dooley et al., 2014; Ganley et al., 
2009; Nishimura et al., 2013), it remains plausible that post-translational modifications (PTMs) can play 
a role in regulating the activities of many ATG proteins. PTMs can provide a quick and reversible 
regulation of ATG proteins during autophagosome biogenesis. Indeed, a number of PTMs of ATG16L1 
have been documented (Fig. 1). For instance, phosphorylation of ATG16L1 (predominantly at S139) is 
stimulated during hypoxia/reoxygenation (H/R) treatment and requires the activity of casein kinase 2 
(CK2) (Song et al., 2015). Mutating the putative CK2 phosphorylation site on ATG16L1 diminished its 
binding to ATG5 and inhibited autophagy (Song et al., 2015). On the contrary, phospho-mimetic 
mutants of this site or inhibiting its dephosphorylation resulted in enhanced binding to ATG5 and 
restored autophagy (Song et al., 2015). This phosphorylation event can be regulated by an adjacent 
methylation of K151, which is decreased during H/R treatment, leading to elevated phosphorylation of 
S139 and enhanced binding to ATG5 (Song et al., 2018). S278 of human ATG16L1 was also shown to be 
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phosphorylated by ULK1 (Alsaadi et al., 2019) although its phosphorylation by IκB kinase α (IKKα) has 
also been described (Diamanti et al., 2017). Antibodies that specifically recognise the S278-
phosphorylated ATG16L1 suggest that this site is modified under various conditions and can be used 
to detect its phagophore localisation (Tian et al., 2020). Phosphorylation of S278 by ULK1 is not 
essential for starvation-induced autophagy (Tian et al., 2020) but is required for the recruitment of 
ATG16L1 to the site of invading bacteria during Salmonella infection (Fig. 2C) (Alsaadi et al., 2019). 
However, these stimulus-dependent modifications of ATG16L1 and the underlying molecular 
mechanisms that affect its autophagic activities remain to be further uncovered.  
Regulation of protein stability of the core autophagy machinery could provide an alternative means to 
modulate their activities. ATG16L1, as well as other ATG proteins, have been identified as substrates for 
protease cleavage (Murthy et al., 2014; Norman et al., 2010). Increased susceptibility of ATG16L1 to 
caspase cleavage has been associated with its pathogenic variants in Crohn’s disease (discussed below) 
(Murthy et al., 2014). In addition, caspase cleavage and destabilisation of ATG16L1 is affected by IKKα- 
or ULK1-mediated phosphorylation of S278 (Alsaadi et al., 2019; Diamanti et al., 2017) and by its protein 
kinase A (PKA)-mediated phosphorylation (Zhao et al., 2019). Given that ATG16L1 overexpression can 
inhibit autophagy, it is possible that fine tuning of its levels may enable the regulation of its activity. 
Indeed, the E3 ubiquitin ligase Gigaxonin  has been described to bind to the WD40 domains region of 
ATG16L1 and result in its degradation (Scrivo et al., 2019). In the absence of Gigaxonin, ATG16L1 levels 
are elevated, leading to its aggregation and autophagy inhibition, thereby imposing deleterious effects 
on neuronal health (Scrivo et al., 2019). Interestingly, Gigaxonin overexpression can dramatically reduce 
ATG16L1 levels and restore autophagic activity in neurons (Scrivo et al., 2019). This is consistent with 
the notion that low levels of some ATG proteins (such as ATG5) has been shown to be sufficient to drive 
autophagy in cells (Hosokawa et al., 2006), and raises the question whether the regulation of ATG 
protein stability is a means to modulate autophagy under all conditions.  
 
Relevance of WD40 domains interactions in non-canonical autophagy and cargo selection  
Unlike for autophagosome biogenesis, C-terminal sequences of ATG16L1 are vital for ATG8 lipidation on 
single membranes, such as perturbed endosomes or entotic bodies (Fletcher et al., 2018; Lystad et al., 
2019). The underlying molecular mechanisms that mediate SMAC remain to be further explored, but it 
has been shown that they require sequences within the WD40 domains and the ATG16L1β-isoform 
specific C-terminal lipid binding region (Fig. 1) (Fletcher et al., 2018; Lystad et al., 2019). The 
physiological relevance of this non-canonical ATG8 lipidation also requires further investigation and 
might be uncovered by utilising transgenic mouse models that express WD40-deficient ATG16L1 (Rai et 
al., 2019; Wang et al., 2020) or lack specific ATG16L1 isoforms.  
WD40 domains are known to mediate protein-protein interactions. Whilst multiple binding partners 
have been mapped to the WD40-containing C-terminal region of ATG16L1, they have not yet been 
confirmed to contribute to non-canonical ATG8 lipidation. These WD40 domains binding partners 
include a subset of transmembrane-containing proteins, (Boada-Romero et al., 2013; Hu et al., 2016; 
Sun et al., 2017), ubiquitin (Fujita et al., 2013), component 3 (C3) (Sorbara et al., 2018) and ATP6V0C 
(Xu et al., 2019). Many of these ATG16L1 interacting partners are dispensable for starvation-induced 
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autophagy and are likely to have roles in autophagic cargo recognition or potentially autophagy-
independent functions.  
The interacting partners of the WD40 domains of ATG16L1 suggest it might have a role in the clearance 
of bacteria by autophagy (known as xenophagy, Fig. 2C), such as the three different transmembrane-
containing proteins TMEM59, TMEM74 and TMEM166 (also known as EVA1A) (Boada-Romero et al., 
2013; Hu et al., 2016; Sun et al., 2017). Overexpression of any of these proteins was shown to induce 
LC3 lipidation. In the case of TMEM59, its overexpression together with ATG16L1 leads to the 
localisation of both proteins to Staphylococcus aureus-positive endocytic vesicles (Boada-Romero et al., 
2013). Binding of the WD40 domains to ubiquitin has also been described and is required for the  
recruitment of ATG16L1 and LC3 to invading Salmonella in the absence of FIP200 (Fujita et al., 2013). 
How FIP200 can compensate for requirement to bind ubiquitin, as well as any unknown factors, 
remains to be investigated. Additional WD40-binding partners of ATG16L1 that may aid its recruitment 
to the site of bacterial infection during xenophagy include C3 and ATP6V0C (Sorbara et al., 2018; Xu et 
al., 2019). The interaction between ATP6V0C and ATG16L1 can be antagonised by the bacterial protein 
SopF as a mechanism to evade bacterial clearance by autophagy and thus enhance replication (Xu et al., 
2019). Furthermore, the  binding of C3 to ATG16L1 may have a role in mediating the survival of 
pancreatic cells in response to diabetogenic stress (King et al., 2019). Altogether, these findings highlight 
the role of ATG16L1 during xenophagy and suggest its relevance in cargo recognition and local activation 
of autophagosome biogenesis. Investigating the effects of smaller deletions or point mutations in the 
WD40 domains of ATG16L1, instead of deleting its entire C-terminus, may help to better understand the 
contribution of individual interacting partners. 
 
Autophagy-independent roles of ATG16L1  
Multiple autophagy-independent roles of ATG16L1 have been reported and are defined here as those 
that do not involve any form of ATG8 lipidation (see Table 1). These functions of ATG16L1 may or may 
not require its interaction with the ATG5-ATG12 conjugate. Some of these autophagy-independent roles 
in mammalian cells are discussed below based on the requirement to bind to ATG5 and additional 
activities in lower organisms are outlined in Box 2. 
 
ATG5-binding dependent ATG16L1 functions 
Several studies have documented a role of ATG16L1 during exocytosis. ATG16L1, along with ATG5, has 
been shown to be involved in exosome production in a manner that includes the lipidation-independent 
recruitment of LC3 to vesicles (Guo et al., 2017). Exosomes can transport material from one cell to 
another and have been implicated in immune response, tumour cell metastasis and neurodegeneration 
(Kalluri and LeBleu, 2020). Genetic inhibition of ATG16L1 or ATG5, but not ATG7, in mouse embryonic 
fibroblasts or human breast cancer cells disrupted the recruitment of LC3 to exosomes and their 
secretion  (Guo et al., 2017). Treating ATG5-null breast cancer cells with exosomes from wild type cells 
before their implantation in mammary pads in mice resulted in enhanced metastasis to the lungs 
compared to implantation of untreated wild type or ATG5-null cells (Guo et al., 2017). The presence of 
ATG16L1, along with the ATG5-ATG12 conjugate, in secretory vesicles from cultured neuroendocrine 
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cells has also been reported and shown to depend on the binding of ATG16L1 to Rab33A (Ishibashi et 
al., 2012). This localisation of ATG16L1 is required for hormonal secretion in a manner that is 
independent of PI(3)P or components of the ULK complex (Ishibashi et al., 2012). ATG16L1 has also been 
found to be involved in lysosomal exocytosis, which is required to restrict cell-to-cell spreading of 
Listeria monocytogenes (Tan et al., 2018). Here, ATG16L1, along with the ATG5-ATG12 conjugate, acts to 
mediate plasma-membrane repair dependently on its WD40 domains, but independently of other 
autophagy players such as ATG3 (Tan et al., 2018). An additional non-autophagic function of the ATG5 
complex has been described in mediating interferon production during viral infection (Hwang et al., 
2012). However, the underlying molecular mechanisms and whether this effect is mediated through 
regulation of the exocytic pathway remain unclear.  
 
ATG5-binding independent roles of ATG16L1 
Fewer non-ATG5-binding dependent roles of ATG16L1 have been described, which might be due to the 
fact that ATG16L1 is destabilised in ATG5-deficient cells (Dudley et al., 2019; Nishimura et al., 2013). One 
of these ATG5-independent roles of ATG16L1 is the ability to suppress cytokine production mediated 
by the intracellular pattern recognition receptors, Nod1 and Nod2 (Trindade and Chen, 2020), in 
response to bacterial infection (Sorbara et al., 2013). This effect of ATG16L1 is suppressed in the Crohn’s 
disease variant ATG16L1T
T300A
 (discussed below), potentially underscoring an autophagy-independent 
pathological role of this variant in inflammatory bowel disease (IBD) (Sorbara et al., 2013).  
 
Link to pathophysiology 
The pathophysiological functions of ATG16L1 are likely mediated through both its autophagy-dependent 
and -independent activities. The first and most extensively studied disease-relevance of ATG16L1 was 
prompted by the discovery of its Crohn’s disease-associated variant ATG16L1
T300A
 (corresponding to β 
isoform residue number) (Hampe et al., 2007). The link between ATG16L1 and intestinal inflammation 
was further confirmed in a number of studies, in which ATG16L1 was specifically deleted in either the 
intestine (Aden et al., 2018; Adolph et al., 2013; Matsuzawa-Ishimoto et al., 2017) or hematopoietic cells 
(Kabat et al., 2016; Saitoh et al., 2008; Samie et al., 2018), and together they demonstrated a protective 
role of ATG16L1 in IBD.  
Despite its discovery as a susceptibility variant over a decade ago (Hampe et al., 2007), research is still 
ongoing to determine the underlying molecular mechanism resulting in the association of 
ATG16L1
T300A
 variant with increased susceptibility to Crohn’s disease. This threonine to alanine 
substitution falls within the WD40 domain of ATG16L1 that is in close proximity to its middle region and 
has been implicated in various functions of ATG16L1; however, the specific protein-protein or protein-
lipid interactions that are affected by this variant are still undetermined (Boada-Romero et al., 2016). 
ATG16L1
T300A
 may also be associated with additional pathological conditions, such as brain metastasis of 
lung cancer (Li et al., 2017b). Further genetic association studies may help to unravel additional diseases 
that are affected by this ATG16L1 variant.  
The most studied molecular consequence of the ATG16L1
T300A
 variant is its enhanced susceptibility to 
cleavage by Caspase-3 and thereby destabilisation (Murthy et al., 2014). Activation of Caspase-3 by 
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nutrient stress or death-receptor signalling stimulates ATG16L1
T300A
 degradation and reduces autophagic 
response as well as clearance of bacterial infection (Murthy et al., 2014). Mice that are hypomorphic for 
ATG16L1 expression or express ATG16L1
T300A
 knock-in mutation exhibited altered intestinal microbiota 
and abnormalities in Paneth cells, specialised secretory cells that line up the intestinal epithelium and 
play an antimicrobial role in protecting the epithelium (Cadwell et al., 2008; Lassen et al., 2014; Lavoie 
et al., 2019). 
Interestingly, variants of Nod2, an ATG16L1-binding partner, have also been associated with increased 
susceptibility to Crohn’s disease. These Nod2 variants are thought to perturb its ability to recruit 
ATG16L1 to the site of bacterial infection, thereby affecting pathogen clearance (Travassos et al., 2010). 
Both ATG16L1 and Nod2 can interact with immunity-related GTPase family M (IRGM) protein, another 
Crohn’s disease-associated gene product (Chauhan et al., 2015). This complex formation is induced by 
microbial products and is required to supress pathogen-induced inflammation (Chauhan et al., 2015). 
An additional binding partner of ATG16L1 that may be linked to its role in IBD is the anti-inflammatory 
protein A20, which binds ATG16L1 through its WD40 domains (Slowicka et al., 2019). Interesting, mice 
harbouring combined tissue-specific deletions of both A20 and ATG16L1, but not individual knockout, 
exhibit IBD-like phenotype, suggesting that both proteins can cooperatively regulate inflammation of the 
bowel (Slowicka et al., 2019). Altogether, these Crohn’s disease-associated interactors of ATG16L1 
underscore its role in inflammatory response with the underlying mechanisms likely requiring its 
activities in autophagy and autophagy-related processes.  
 
Conclusions and final remarks 
As research continues to expand our knowledge of how ATG proteins function during autophagy, 
numerous questions remain unresolved. In terms of ATG16L1, recent studies have highlighted the 
importance of its various domains that engage in diverse steps of autophagosome biogenesis as well as 
during non-canonical SMAC. This raises the question of whether specific domain mutations of ATG16L1 
could be used as tools to determine the physiological relevance of canonical autophagy and non-
canonical ATG8 lipidation. Furthermore, it is also unclear what are the tissue-specific functions of the 
ATG16L1 isoforms. In addition, how ATG16L1 activity is regulated, i.e. whether there are any on/off 
switches, and what mediates its recognition of single membranes are other important aspects that 
warrant further investigation. Finally, the involvement of ATG16L1 in pathological conditions is also an 
area of ongoing research, and it remains to be addressed whether the underlying mechanisms involve 
its canonical or non-canonical autophagic functions, or instead require its largely unexplored non-
autophagic activities.   
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Table 1. A summary of autophagy-dependent and -independent activities of ATG16L1.  
Activity Function References 
Autophagosome formation   
Binding to FIP200 
Relaying upstream signalling from 
the ULK complex (Dooley et al., 2014; Dudley et al., 
2019; Gammoh et al., 2013; 
Nishimura et al., 2013) Phagophore recruitment of ATG5-ATG12 
(binding to WIPI2b, FIP200 and PI(3)P) 
Specifying site of ATG8 lipidation 
E3-like ligase activity  
(ATG5-ATG12 and N-terminal lipid-
binding) 
ATG8 lipidation & autophagosome 
maturation  
(Lystad et al., 2019; Otomo et al., 
2013) 
Localisation to endocytic vesicles  Phagophore growth 
(Moreau et al., 2011; Puri et al., 
2013; Ravikumar et al., 2010) 
Multimer formation Scaffolding phagophore growth (Kaufmann et al., 2014) 
Binding to Rab GTPases Autophagosome-lysosome fusion? 
(Itoh et al., 2008; Itoh et al., 
2011) 
Non-canonical ATG8 lipidation (SMAC) & cargo recruitment  
Unknown protein/lipid binding partner 
within the WD40 domains 
Recruitment to single membranes 
and subsequent ATG8 lipidation  
(Fletcher et al., 2018) 
C-terminal β isoform lipid-binding activity  
ATG8 lipidation on single 
membranes 
(Lystad et al., 2019) 
WD40 domains interactions with: 
Ubiquitin, TMEMs, C3 and ATP6V0C 
Relevance in recognising bacterial 
infections 
(Boada-Romero et al., 2013; 
Fujita et al., 2013; Hu et al., 2016; 
Sorbara et al., 2018; Sun et al., 
2017; Xu et al., 2019) 
Autophagy-independent   
Regulation of V1V0-ATPase activity via 
ATG5 binding 
Exosome production (Guo et al., 2017) 
Rab33A binding Hormone secretion (Ishibashi et al., 2012) 
Undefined WD40-dependent activity 
Lysosome exocytosis and plasma 
membrane repair 
(Tan et al., 2018) 







Box 1. A brief overview of autophagosome formation 
Autophagy occurs at basal levels in cells and can be further induced upon various stimuli such as 
nutrient and oxygen deprivation as well as genotoxic and cytotoxic stress (Antonucci et al., 2015; 
Kroemer et al., 2010; Mizushima et al., 2004). A number of signalling cascades can regulate autophagy 
(Russell et al., 2014). In the case of nutrient deprivation, the mammalian target of rapamycin complex 1 
(mTORC1) and AMP-activated protein kinase (AMPK) pathways have been most widely studied with 
respect to their abilities to suppress or activate autophagy, respectively. These sensing complexes act to 
regulate autophagy by mainly phosphorylating members of the Unc-51-like kinase (ULK) complex, 
although additional regulatory mechanisms have been described (Wong et al., 2013). The ULK complex 
is important for the regulation of autophagy during nutrient sensing (Ganley et al., 2009; Hosokawa et 
al., 2009; Jung et al., 2009; Mercer et al., 2009). Optimal kinase activity of ULK1 requires 
autophosphorylation and binding to its adaptor proteins and acts to activate downstream players 
including the VPS34 complex (Wong et al., 2013; Zachari and Ganley, 2017). The VPS34 complex, 
comprised of the VPS34 lipid kinase, ATG14, Beclin-1 and VPS15 (Itakura et al., 2008), catalyses the 
production of PI(3)P on the phagophore, which is essential for the recruitment of subsequent ATG 
players (including WIPI2, ATG5 complex and ATG2 proteins) as well as for ATG8 lipidation (Dudley et al., 
2020). The final stages of autophagy involve autophagosome maturation and closure followed by 
lysosome fusion (forming the autolysosome) and require the lipidation of the ATG8 family members for 
its efficient execution (Johansen and Lamark, 2020; Nakamura and Yoshimori, 2017; Nguyen et al., 
2016). Fusion between autophagosomes and lysosomes in the absence of ATG8 lipidation has been 
reported but occurs at a slower rate (Tsuboyama et al., 2016). The ATG8 family members are also 
involved in cargo and cargo receptor recognition although upstream ATG proteins (such as FIP200) may 
also play a role (Kirkin and Rogov, 2019; Turco et al., 2019). Lipidated ATG8s tethered to the outer 
autophagosomal membrane can be delipidated by the action of ATG4 proteases and recycled back to 
the cytoplasm (Maruyama and Noda, 2017). 
 
Box 2. Relevance of ATG16L1 in autophagy-independent activities in non-mammalian organisms. 
Autophagy-independent roles of ATG16L1 have also been described in invertebrates. Drosophila 
mutants lacking Atg16 or expressing a truncation mutant that does not bind Atg5 exhibited reduced 
sensitivity to ethanol-induced sedation whereas flies lacking Atg7 or Atg3 showed no altered response 
to ethanol exposure (Varga et al., 2016). This increased resistance to ethanol is mediated by a defect 
in Corazonin production and secretion in Atg16 mutant flies (Varga et al., 2016). Individual or 
combined deletions of Atg16, Atg5 and Atg12 in the social amoeba Dictyostelium discoideum 
exhibited similar autophagy-related phenotypes as observed with other Atg deletions, including 
developmental abnormalities and reduced survival during nitrogen starvation (Karow et al., 2020). 
However, D. discoideum harbouring a combined triple deletion of Atg16, Atg5 and Atg12 showed 
increased defect in macropinocytosis of fluorescent-dextran and phagocytosis of yeast cells when 
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compared to Atg5 and Atg12 co-deletion alone, thereby suggesting additional non-autophagic and 
potentially redundant activities of these proteins (Karow et al., 2020). Altogether, these findings 
suggest that the autophagy-independent roles of Atg16 are also observed in varying species with the 








Fig. 1. Domain organisation of ATG16L1. 
Major domains, interacting partners (protein and lipids) and activities of ATG16L1 are highlighted. 
Denoted above the protein are various regions mediating ATG16L1 activities including those involved in 
double membrane autophagosome and single membrane vesicle ATG8 lipidations. Interacting partners 
are also denoted diagonally above the protein. PTMs are shown underneath the protein using oval 
arrowheads (S139 and S278 phosphorylation), diamond arrowhead (K151 methylation), square 
arrowhead (T300 Crohn’s disease associated variant) and broken line (D299 caspase cleavage site). 
 
Fig. 2. Relevance of ATG16L1 during autophagosome biogenesis and single membrane ATG8 lipidation. 
A) Autophagosome biogenesis requires the formation of a precursor, double membrane structure 
termed the phagophore. ATG16L1 is recruited to the phagophore through its ability to bind FIP200, 
WIPI2b and PI(3)P. The localisation of ATG16L1 to endocytic vesicles (recycling endosomes) suggest its 
function in contributing to phagophore growth. These events facilitate ATG8 lipidation on the 
phagophore and contribute to autophagosome maturation, which subsequently fuse with the 
lysosome system forming an autolysosome. B) Single membrane ATG8 conjugation (SMAC) occurs on 
pre-formed vesicles such as entotic bodies, phagocytosed bacteria and perturbed endosomes. This 
requires various domains within ATG16L1 including N-terminal sequences (ATG5 and lipid binding), β 
isoform lipid binding and sequences within the WD40 domain. C) ATG16L1 is also involved in initiating 
autophagosome biogenesis at the site of invading bacteria during xenophagy (double membrane 
autophagosome) as well as initiating SMAC on phagocytosed bacteria (single membrane vesicles). 
Recognising invading bacteria by ATG16L1 requires various binding partners of the WD40 domains and 
is enhanced by S278 phosphorylation (pS278).  
 
Fig. 3. Comparison of ATG16L1-related proteins. 
Comparison of mammalian ATG16L1 (α, β and γ isoforms) and ATG16L2 as well as yeast Atg16 proteins. 
The relevant binding partners and dimerisation capacity are compared in the table. Not yet tested 
activities are marked with a question mark (?) and predicted activities based on sequence similarities are 
marked with a grey check mark ( ). Diagrams on the right depict major domains and relative length. 
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Notes & distinctive features
ATG16L1 α ✓ ✓ ✓ ✓ ✓ ✓ X
Lacks C-terminal sequences required for 
single membrane ATG8 lipidation
ATG16L1 β ✓ ✓ ✓ ✓ ✓ ✓ ✓
Supports single & double membrane 
ATG8 lipidation
ATG16L1 γ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Longest ATG16L1 isoform mainly 
expressed in the brain & heart
ATG16L2 ✓ ✓ X X ? ? ?
Divergence of unspecified middle region 
sequences results in autophagic inactivity
Atg16 
(Yeast)
✓ ✓ N/A N/A ? ? N/A
Lacks C-terminal sequences including the 
WD40 domains 
CCD WD40 domains
CCD WD40 domains
CCD WD40 domains
CCD
CCD WD40 domains
